medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2004, Number 3

<< Back Next >>

Rev Mex Oftalmol 2004; 78 (3)

Salvamento ocular en retinoblastoma

Rangel-Charqueño MG, Ordaz-Favila JC, Juárez-Echenique JC

Language: Spanish
References: 15
Page: 111-117
PDF size: 133.11 Kb.


ABSTRACT

Purpose: To determine the characteristics of the patients with diagnosis of retinoblastoma with treatment of eye saving.
Material and methods: We did a descriptive study, where we check 66 patients files with diagnosis of retinoblastoma with treatment of eye saving (6 unilateral, 66 bilateral), from 1998 to 2002.
Results: We registered eye saving in unilateral retinoblastoma in 6 patients (6 eyes) and in bilateral retinoblastoma in 4 patients in both eyes (8 eyes) and in 46 patients in one of the eyes (46 eyes), with a total of 60 eyes (47.6%). Enucleation was performed in 10 patients in both eyes (20 eyes) and in one of the eyes in 46 patients (46 eyes), with a total of 66 eyes (52.4%). Vision was conserved in one of the eyes in 56 patients (84.8%).
Conclusions: Eye saving in unilateral retinoblastoma was obtained in 100%, in bilateral retinoblastoma has been a challenge and saving was obtained only in 4 patients bilaterally and in 46 patients unilaterally, which have been kept vision. Saving eye was obtained by conservative methods, but also depends on early diagnosis, clinical characteristics and attachment in treatment.


REFERENCES

  1. Lommatzsch PK. Tumores intraoculares. Diagnóstico Diferencial en Color. España; Marbán, 1993.

  2. Wright K y col. Los Requisitos: Oftalmología Pediátrica y Estrabismo. España; Harcourt, 2001.

  3. Basic and Clinical Science Course. Pediatric Ophthalmology and Strabismus. San Francisco, 2001-2002

  4. Gallin PF. Pediatric Ophthalmology. Nueva York; Thieme Medical Publishers Inc., 2000.

  5. Gangadhara JK, Krishnakumor S, Biswas J. Retinoblastoma Presenting as Panophthalmitis: Clinicopathological Study of a Case. J Pediat Ophthal Strab, 2002; 39:178-180.

  6. Duane T y col. Clinical Ophthalmology. The Retinoblastoma. Philadelphia; Harper and Row, 2000.

  7. Shields CL, Shields JA. Recent Developments in the Management of Retinoblastoma. J Pediat Ophthal Strab, 1999; 36:8-18.

  8. Shields JA, Shields CL, Sivalingam V. Decreasing Frequency of Enucleation in Patients with Retinoblastoma. Ophthalmology, 1989; 108:185-188.

  9. Shields JA, Shields CL, Parsons H y col. The Role of Photocoagulation in the Management f Retinoblastoma. Arch Ophthalmol, 1990; 108:205-208.

  10. Wong FL, Boice JD, Abramson DH y col. Cancer incidence after Retinoblastoma. Radiation dose and sarcoma risk. JAMA, 1997; 278:1262-1267.

  11. Shields JA, Parsons H, Shields CL y col. The Role of Cryotherapy in the Management of Retinoblastoma. Ophthalmology, 1989; 108:260-264.

  12. Gündüz K, Shields CL, Shields JA y col. The Outcome of Chemoreduction Treatment in patients with Reese-Ellsworth Group V Retinoblastoma. Arch Ophthalmol, 1998; 116:1613-1617.

  13. Jusitab MS, Van Quill KR, Scott IU y col. Evaluation of Chemoprophylaxis in Patients With Unilateral Retinoblastoma With High-Risk Features on Histopathologic Examination. Arch Ophthalmol, 2001; 119:41-48.

  14. Lam BL, Judisch GF, Sobol WM y col. Visual Prognosis in Macular Retinoblastoma. Ophthalmology, 1990; 110:229-232.

  15. Abramson DH, Du T. Beaverson KL. Retinoblastoma in the First Month of Life (Neonatal). Arch Ophthalmol, 2002; 120:738-742.




2020     |     www.medigraphic.com